my account  log out
 

Mifepristone

Create: 09/28/2016
Expired Date:09/30/2019
Category: Estrone [Health&Medical&Pharmaceutical]
Message: Mifepristone Molecular Formula:C29H35NO2 CAS Registry Number:84371-65-3 Synonyms:Estra-4,9-dien-3-one,11-[4-(dimethylamino)- phenyl]-17-hydroxy-17-(1-propynyl)-,(11a,- 17a)-; Mifepristone [USAN:BAN:INN]; 17-beta-Hydroxy-11-beta-(4-dimethylaminophenyl-1)-17-alpha-(prop-1-ynyl)oestra-4,9-dien-3-one; Mifeprex; Mifepristonum [Latin]; R 38486; RU 38486; 11beta-(4-(Dimethylamino)phenyl)-17beta-hydroxy-17-(1-propynyl)estra-4,9-dien-3-on; Estra-4,9-dien-3-one, 11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(1-propynyl)-, (11b,17b)-; Prestwick_570; Mifegyne; (11beta,17beta)-11-(4-(Dimethylamino)-phenyl)-17-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one; RU-486; RU486; 11beta-(4-(Dimethylamino)phenyl)-17-hydroxy-21-methyl-19-nor-17alpha-pregna-4,9-dien-20-m-3-on; RU 486-6; 17-(1-propynyl)estra-4,9-dien-3-one; Chemical Properties Appearance:Pale Yellow Solid Molecular Weight:429.5937 Density:1.18 g/cm3 Boiling Point:628.6 °C at 760 mmHg Melting Point:195-198°C Flash Point:334 °C Storage Temperature:2-8°C Refractive index:1.623 Solubility:Soluble to 100 mM in DMSO and to 50 mM in Ethanol Biological Activity:Selective antagonist at progesterone (PR) and glucocorticoid (GR) receptors in vitro and in vivo . Is a silent antagonist at PR and has a higher affinity than progesterone. Has higher affinity for GR than dexamethasone. Stability:Stable at normal temperatures and pressures. Usage:A progesterone receptor antagonist with partial agonist activity. Abortifacient. For more details, please contact cindy1114@yccreate.com
City:Wuhan Hubei[CN] 
Location:
 
Sep 29 20163,6-Dichloropyridazine365
Sep 29 2016Cephalomannine373
Sep 29 2016 Notoginseng Triterpenes379
Sep 29 2016 Xanthophyll from alfalfa388
Sep 29 2016 Escin405
Sep 29 2016Eugenol379
Sep 29 2016Scopolamine Butylbromide381
Sep 29 2016 Caryophyllene375
Sep 29 2016 L(-)-Menthol375
Sep 29 2016DHA Powder Schizochytrium363

return back

Copyright © toextrade Inc. All rights reserved. Contact us